A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT03015519 · WITHDRAWN
Trial details
- NCT number
- NCT03015519
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2020-04-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.